Disruption of SHOC2-RAS interaction for therapeutic targeting of RAS-mutant cancers
Hauseman, Z.J., Stauffer, F., Beyer, K.S., Molle, S., Cavicchioli, E., Marchand, J.R., Fodor, M., Viscomi, J., Handl, C., Dhembi, A., Katz, S., Faggion, B., Kerr, G., Schildknecht, D., Maddalo, D., Pissot Solderman, C., Brady, J., Shrestha, O., Nguyen, Z., Leder, L., Cremosnik, G., Lopez Romero, S., Hassiepen, U., Stams, T., Linder, M., Galli, G.G., Guthy, D.A., King, D.A., Maira, S.M., Thoma, C.R., Ehmke, V., Tordella, L.To be published.